CHICAGO, IL – As of June 10th, 2025, we are excited to announce that heartbase™ is officially certified by the ACC-NCDR for Version 1.4 of the LAAO Registry Database.
On July 23rd, 2025, at 12:00 pm CT, heartbase clinical specialist Carmen Ernst, RN, BSN, will hold a special training class covering the ins and outs of this registry module. Heartbase customers can click here to register. Heartbase staff highly recommends that hbCOR users attend this session or view the recording.
For customers wanting to learn more about this module, Alex Potanos will host a general information session on June 27th at 3 pm CT as part of the heartbase Virtual User Conference. Please click here to register.
From the ACC-NCDR website:
“Get the support you need to ensure quality patient care for your atrial fibrillation patients with the American College of Cardiology’s LAAO Registry™.
Join the first national registry capturing data on left atrial appendage occlusion procedures to assess real-world procedural outcomes, short and long-term safety, comparative effectiveness and cost effectiveness. LAAO provides a treatment option to manage stroke risk for non-valvular atrial fibrillation patients who are unable to maintain adequate anticoagulation through medication therapy.”
Participation offers:
- The LAAO Registry is approved by the Centers for Medicare and Medicaid Services (CMS) to meet the registry requirements outlined in the national coverage decisions for Percutaneous Left Atrial Appendage Closure.
- Integration & Interoperability with other heartbase hbCOR registry events.
- Interoperability options from other hospital systems, such as Epic Clarity, allow for the pre-population of discrete fields.
- A comprehensively streamlined & customizable electronic DCF, improving upon the flow and functionality of the ACC Online Tool, with options such as role-based access.
- Simplified reporting with the hbQuery Tool, with measure reporting and other standard reports to follow.
- Integration with the hbRecon Module to ensure LAAO procedures and associated MCCs are correctly coded and billed, maximizing reimbursement to MS-DRG 273, 274, & 317.
- Planned hbAnalytics updates to include new measure reporting and associated breakout reports.
About heartbase, Inc.
Heartbase™ is a privately-held company founded in 1992 and designed to be intuitive & centered on the needs of the clinician. Since our inception, we have known that the most effective way to develop a robust and reflexive software platform is through collegial partnerships with our clinical & financial users. Working directly with our customers – listening to their concerns and honoring their suggestions for improvement – allows us to build a tool that is fast, efficient, and tailored specifically to the individual needs of each healthcare institution.
Our primary major business lines are the following: hbCOR, Data Capture & Reporting; hbAnalytics, Realtime Clinical & Financial Dashboards; hbRecon, Coding Reconciliation & Revenue Generation; & hbNote, Data First Structured Reporting.